Form 4 for ABBV AbbVie
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-20 · accession 0001179110-21-011176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-12-20 | ABBV | Durkin Brian L | VP, Ctrl | S - Sale+OE | $128.51 | -11.8K | 16.5K | -42% | -$1.52M |
| D | 2021-12-21 | 2021-12-20 | ABBV | Durkin Brian L | VP, Ctrl | M - OptEx | $61.36 | +7,180 | 28.3K | +34% | +$440.6K |
| D | 2021-12-21 | 2021-12-20 | ABBV | Durkin Brian L | VP, Ctrl | M - OptEx | $61.36 | -7,180 | 0 | -100% | -$440.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2021-12-20 | S | D | 11,790 | $128.51 | 16,505 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2021-12-20 | M | A | 7,180 | $61.36 | 28,295 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-12-20 | M | D | 7,180 | $61.36 | 0 | D | $0.00 · 2018-02-16 to 2027-02-15 | 7,180 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |